Wiki Chemo question

rosa123

Guest
Messages
21
Best answers
0
Pt. received in the office regular chemo treatment, taxotere 2hrs 45min and carboplatin 35 min, she also received kytril and dexamethasone IV push, pt develop an episode of nausea and vomiting, and therefore pt. received another course of kytril and dexa, IV push. Will bill for drugs + infusion as follow. Diagnosis v58.11; 787.01;174.9
96413 (1)
96415 (1)
96417 (1)
96375 (2)
96376 (2)
is this correct?
 
chemo question

96376 can only be used in the facility setting not physician office
please see attached article hope this helps

Vickie



Journal of Oncology Practice

Skip to main page content



Search GO

Advanced Search ?









User Name

Password
Sign In

HOME
Search
Browse BY TOPIC
ARCHIVE
Early Release
Podcasts
Supplements
ALERTS

Advertisement
<SCRIPT language='JavaScript1.1' SRC="http://ad.doubleclick.net/adj/N7417.279955JOURNALOFONCOLOGYPRA/B8483427.114920733;abr=!ie;sz=728x90;click0=http://oascentral.jop.ascopubs.org/RealMedia/ads/click_lx.ads/jop/fulltext/L12/560928315/Top/ASCO/JOP_Genentech_Gazyva_Feb-Mar/Gazyva_Leader-Feb15.html/58535267616c554f38425941426b534d?;ord=560928315?"> </SCRIPT> <NOSCRIPT> <A HREF="http://oascentral.jop.ascopubs.org/RealMedia/ads/click_lx.ads/jop/fulltext/L12/560928315/Top/ASCO/JOP_Genentech_Gazyva_Feb-Mar/Gazyva_Leader-Feb15.html/58535267616c554f38425941426b534d?http://ad.doubleclick.net/jump/N7417.279955JOURNALOFONCOLOGYPRA/B8483427.114920733;abr=!ie4;abr=!ie5;sz=728x90;ord=560928315?"> <IMG SRC="http://ad.doubleclick.net/ad/N7417.279955JOURNALOFONCOLOGYPRA/B8483427.114920733;abr=!ie4;abr=!ie5;sz=728x90;ord=560928315?" BORDER=0 WIDTH=728 HEIGHT=90 ALT="Advertisement"></A> </NOSCRIPT>




















Copyright ? 2009 by American Society of Clinical Oncology.

Billing for Multiple Injections or Intravenous Pushes of the Same Drug

The American Medical Association's (AMA) Current Procedural Terminology (CPT) manual provides a listing of the services and procedures performed by health care providers. The medical terminology and code definitions printed in the manual assist in providing uniformity to describe medical, surgical, and diagnostic procedures. The manual also provides coding clarifications and guidelines in the section preambles and code parentheticals; however, not all questions can be answered by these instructional notes.

A common question that is submitted to ASCO's coding and reimbursement staff is how to report multiple injections or intravenous pushes of the same drug. The CPT manual provides clear, concise instructions on how to code for multiple intravenous pushes of the same substance or drug when administered in a facility (eg, hospital):

?96376?Each additional sequential intravenous push of the same substance/drug provided in a facility.


?96376 is not to be reported when a push is performed within 30 minutes of a reported push of the same substance or drug.


?96376 may be reported by facilities only.


There is no clear guidance on billing for multiple intravenous pushes of the same medication in the office setting. When ASCO suggested that office-based physicians also be allowed to use the multiple push code, the response was that multiple pushes were not as typical in the office setting as the hospital setting. Consequently, no CPT code exists for the administration of multiple pushes of the same drug in the office setting. Given that there is no code, the CPT manual neither provides instructions nor does it address billing guidance.

ASCO's understanding of billing for multiple intravenous pushes is that if a provider administers multiple pushes of the same drug, he or she would not be able to report the additional administrations. However, the total amount of drug administered would be reportable.

With respect to billing for multiple injections, ASCO asked the Centers for Medicare and Medicaid Services (CMS) to clarify how these services should be reported. The CMS response was to defer to local contractors on this policy, as it has elements of reasonableness and medical necessity. ASCO offers the following billing option when billing for multiple injections; however, providers should always verify the billing guidelines with their local Medicare contractors.

If a provider wishes to report multiple injections (intramuscular or subcutaneous) of the same therapeutic medication, he or she may choose to report code 96372 (therapeutic, prophylactic, or diagnostic injection [specify substance or drug]). The number of administrations would be reported as the units of service. Again, the provider will want to verify the billing guidelines with his or her local Medicare contractor.

When CPT guidelines do not exist, one can turn to Medicare for additional guidance or instructions. CMS may provide coverage and billing guidance for services that are not clarified or detailed in the CPT manual. The local Medicare contractors may also publish coverage policies or billing articles that provide guidance on such issues.

It is important to note that private payers do not have to follow Medicare rules. If there is a question as to how a particular service should be reported and no guidance exists in the CPT manual, one should verify the policy with each individual payer.


Notes

Please send your comments on this article and/or coding questions to jopeditorsdesk@asco.org








































































































rss feed

















Copyright ? 2015 by the American Society of Clinical Oncology










<SCRIPT language='JavaScript1.1' SRC="http://ad.doubleclick.net/adj/N7417.279955JOURNALOFONCOLOGYPRA/B8483427.114907208;abr=!ie;sz=160x600;click0=http://oascentral.jop.ascopubs.org/RealMedia/ads/click_lx.ads/jop/fulltext/L12/2080791150/TopRight/ASCO/JOP_Genentech_Gazyva_Feb-Mar/Gazyva_SkyT-Feb15.html/58535267616c554f38425941426b534d?;ord=2080791150?"> </SCRIPT> <NOSCRIPT> <A HREF="http://oascentral.jop.ascopubs.org/RealMedia/ads/click_lx.ads/jop/fulltext/L12/2080791150/TopRight/ASCO/JOP_Genentech_Gazyva_Feb-Mar/Gazyva_SkyT-Feb15.html/58535267616c554f38425941426b534d?http://ad.doubleclick.net/jump/N7417.279955JOURNALOFONCOLOGYPRA/B8483427.114907208;abr=!ie4;abr=!ie5;sz=160x600;ord=2080791150?"> <IMG SRC="http://ad.doubleclick.net/ad/N7417.279955JOURNALOFONCOLOGYPRA/B8483427.114907208;abr=!ie4;abr=!ie5;sz=160x600;ord=2080791150?" BORDER=0 WIDTH=160 HEIGHT=600 ALT="Advertisement"></A> </NOSCRIPT>

Advertisement
<SCRIPT language='JavaScript1.1' SRC="http://ad.doubleclick.net/adj/N7417.279955JOURNALOFONCOLOGYPRA/B8483427.114907208;abr=!ie;sz=160x600;click0=http://oascentral.jop.ascopubs.org/RealMedia/ads/click_lx.ads/jop/fulltext/L12/1969889856/Right1/ASCO/JOP_Genentech_Gazyva_Feb-Mar/Gazyva_SkyB-Feb15.html/58535267616c554f38425941426b534d?;ord=1969889856?"> </SCRIPT> <NOSCRIPT> <A HREF="http://oascentral.jop.ascopubs.org/RealMedia/ads/click_lx.ads/jop/fulltext/L12/1969889856/Right1/ASCO/JOP_Genentech_Gazyva_Feb-Mar/Gazyva_SkyB-Feb15.html/58535267616c554f38425941426b534d?http://ad.doubleclick.net/jump/N7417.279955JOURNALOFONCOLOGYPRA/B8483427.114907208;abr=!ie4;abr=!ie5;sz=160x600;ord=1969889856?"> <IMG SRC="http://ad.doubleclick.net/ad/N7417.279955JOURNALOFONCOLOGYPRA/B8483427.114907208;abr=!ie4;abr=!ie5;sz=160x600;ord=1969889856?" BORDER=0 WIDTH=160 HEIGHT=600 ALT="Advertisement"></A> </NOSCRIPT>

Advertisement
 
Top